The inhibition of vaccination by maternal antibodies is a widely observed phenomenon in human and veterinary medicine. Maternal antibodies are known to suppress the B cell response. This is similar to antibody feedback mechanism studies where passively transferred antibody inhibits the B cell response against particulate antigens due to epitope masking. In the absence of experimental data addressing the mechanism underlying inhibition by maternal antibodies, it has been suggested that epitope masking explains the inhibition by maternal antibodies, too. Here we report that in the cotton rat 
Introduction
Maternal antibodies of the IgG antibody class are transferred from mother to child and protect children against infectious diseases. Over time, passively transferred maternal antibody titers decline and are not protective any longer but interfere with successful vaccination. A well documented example of this is measles vaccination (for review 1 ).
For personal use only. on April 13, 2017 . by guest www.bloodjournal.org From Inoculation of seronegative children with a live-attenuated vaccine measles virus (MV) leads first to the development of antibodies specific for the nucleocapsid (MV-N) protein (which is released by infected cells), and subsequently to protective neutralizing antibodies specific for the hemagglutinin (MV-H) and fusion (MV-F) proteins 2 .
Neutralizing antibodies recognize at least fifteen non-overlapping neutralizing epitopes on MV-H and three on MV-F 3 . Vaccination in the presence of maternal antibodies, however, does not lead to development of protective neutralizing antibodies (for review 4 ) whereas the T cell response is readily detectable 5, 6, 7, 8, 9, 10 . These findings indicate a specific inhibition of B cell responses by maternal antibodies. In the absence of experimental data, inhibition of B cells has been postulated to be due to physical blockage of epitopes by maternal antibodies (epitope masking 11 ). This model is based on antibody feedback mechanism studies (for review 12, 11 ). In these studies, passive transfer of IgG suppresses the B cell response against sheep red blood cells (SRBC). Epitope masking leads to epitope specific suppression at lower antibody concentrations whereas at higher antibody concentrations also non-epitope-specific inhibition was observed and explained by steric hindrance 13 . A proposed alternate mechanism is based on the only inhibitory receptor of the IgG binding Fc receptor family, Fcγ-IIB receptor (FcγRIIB).
On B cells, cross-linking of FcγRIIB to the B cell receptor (BCR) through
antigen/antibody complexes leads to inhibition of activation and antibody secretion 15, 16, 12, 14 . This mechanism was dismissed for the antibody feedback model because IgG is inhibitory in Fc-receptor knock-out mice 17 , an IgG3 isotype antibody which in the mouse does not bind to FcγRIIB can be inhibitory 18, 19 and in some studies F(ab') 2 fragments
can also inhibit B cell responses 20, 21, 17 .
For personal use only. on April 13, 2017 . by guest www.bloodjournal.org From In summary, these studies provide evidence for epitope masking as the main mechanism of inhibition of antibody responses in the antibody feedback model. Whether the same mechanism applies to B cell inhibition by maternal antibodies has not been addressed experimentally. We have investigated this question in the cotton rat model (Sigmodon hispidus) of measles virus vaccination (for review 22 ). As in humans, maternal antibodies inhibit seroconversion in cotton rats 23 . Natural maternal antibodies can be replaced by transfer of heterologous MV-specific IgG which inhibit seroconversion after vaccination to the same degree 23, 24 and allow experimental manipulation of the system.
Similar to humans, the B cell response is the target of inhibition whereas the T cell response is relatively unaffected 10 .
Materials and Methods
Cotton rats. Inbred cotton rats (Sigmodon hispidus) were purchased from Harlan Laboratories, Inc. For immunization experiments in the presence of MV specific antibodies a specified amount of antibody was injected intraperitoneally into cotton rats.
One day later, animals were immunized with 10 5 pfu of MV (Schwarz strain) subcutaneously. The only exception to this schedule was the experiment testing MVspecific human F(ab') 2 fragments for their inhibitory capacity ( Figure 5 b), were animals were immunized four hours after injection of antibodies. All animal experiments were approved by the IACUC of the Ohio State University.
Cells and measles virus.
The Schwarz vaccine strain of measles virus was grown and titrated on Vero cells according to standard procedures 25 .
For personal use only. on April 13, 2017 . by guest www.bloodjournal.org From Antibodies. Human MV specific polyvalent IgG (Carimmune) was purchased from ZLB Behring. Mouse monoclonal antibodies used in this study have been described elsewhere 26 . The antibodies specific for measles virus hemagglutinin are all neutralizing and recognize different adjacent epitopes (clone K17; epitope B; IgG2a), (clone K29; epitope C; IgG1), (clone K71; epitope D; IgG2a), (clone K83; epitope E; IgG2a), (clone L77; epitope F; IgG2a) in region amino acid 368 to 400. The monoclonal antibody against the nucleocapsid protein (clone F227; IgG2a) does not neutralize. Monoclonal antibodies recognizing the hemagglutinin of the IgM class were produced according to standard procedures 26 and were selected for hemagglutinin recognition. All IgM antibodies are not neutralizing. They were titered by ELISA and an optical density of twice the background was arbitrarily assigned an ELISA unit of 1 (EU). Both MV-specific IgG and
IgM monoclonal antibodies were produced in a miniPERM™ classic bioreactor (Greiner, Germany). IgG was purified using protein A sepharose columns (Montage® Antibody purification kits, Millipore). F(ab') 2 fragments were generated by pepsin digestion (Pierce ImmunoPure F(ab') 2 Preparation Kit). were developed and absorbance read as described above.
Neutralization assay. The neutralization assay was performed as described 23 .
B cell ELISPOT assay. After overnight incubation, plates were washed with PBS/0.05% Tween 20. Plates were incubated with rabbit anti-cotton rat IgG (Virion Systems) and subsequently with goat anti-rabbit alkaline-phosphatase conjugated IgG (Zymed) in PBS/10% cotton rat serum.
For development of spots, plates were washed three times with PBS and 3% agarose containing AMP-BCIP (Sigma) substrate was added. Plates were incubated at room temperature for 2 hours and spots were counted under a light microscope.
Immunoglobulin binding assay. The immunoglobulin binding assay was performed as described for human IgG Again, addition of C3d restored its ability to stimulate MV-specific B cells (Figure 5a ). 
MV-specific IgM overcomes inhibition by MV-specific

Discussion
The inhibition of vaccination by maternal antibodies is a well documented phenomenon in human and veterinary medicine. For measles virus vaccination, the level of maternal antibody is inversely correlated with vaccination success as shown in experimental studies in cotton rats 10 and clinical studies in humans 5 , 33 , 7 , 8 , 34 . The latter demonstrated that at the age of six months, maternal antibody titers are still high enough to suppress seroconversion, at the age of nine months vaccination campaigns are relatively successful, whereas the complete disappearance of antibody at the age of 12 months seems to be optimal for immunization. Based on data from the antibody feedback mechanism and other studies, four mechanisms have been discussed to explain inhibition of vaccination by maternal antibodies: antigen removal, neutralization of vaccine virus, epitope masking and a regulatory (inhibitory) role of FcγRIIB 11, 35 .
Against the potential mechanism of removal of vaccine-IgG complexes speaks the fact that T cells are being produced after immunization in the presence of maternal antibodies although antibody secretion is markedly inhibited 5, 6, 7, 8, 9 . Also neutralization of vaccine virus does not seem to be a mechanism, as immunization with not replicating vaccines is is not able to inhibit B cell activation (in vitro) or generation of neutralizing antibodies (in vivo).
In some antibody feedback mechanism studies, F(ab') 2 fragments do not inhibit immunization 41, 42, 19, 43 . In addition, the inhibitory potential of an antibody is markedly reduced if its interaction with FcγRIIB is abolished by deglycosylation 44 . However, inhibition through FcγRIIB has been dismissed as a possible mechanism based on three observations: an IgG3 isotype antibody which in the mouse does not bind to FcγRIIB can be inhibitory 18, 19 in some studies F(ab') 2 fragments can also inhibit B cell responses 20 , 21 , 17 and IgG is inhibitory in Fc-receptor knock out mice 17 . The interpretation of the latter study is difficult because gene deletion of the FcγRIIB leads not only to an unregulated B 45 but also to defects in macrophage, NK cell and T cell function 46 and higher susceptibility to autoimmune diseases 47, 48 . In our studies, the inability of K29 to interact with activated cotton rat B cells and to inhibit vaccination is consistent with a regulatory role of FcγRIIB. Also the use of F(ab') 2 fragments demonstrated that binding of antibody to the epitope alone is not sufficient to inhibit vaccination with measles virus. Because F(ab') fragments degrade faster than complete IgG 31 we used twice the amount of F(ab') fragments than IgG (based on neutralization titer) and immunized four hours after application of antibody (instead of 24 hours later).
Our data from this study point to a regulatory model for maternal antibodies through cross-linking of FcγRIIB to BCR via an antibody-MV complex (as outlined in figure 6 ). In agreement with this model, IgM is able to restore B cell function partially (in vivo) or fully (in vitro) in the presence of MV-specific IgG which recognize different epitopes. The requirement of the complement protein C3d also supports a regulatory role through cross-link of BCR and complement receptor 2 complex.
After a pathogen specific response has been developed it is thought to be important for the immune system to prevent an overshooting secondary immune response 14 . In patients and experimentally, it has been shown that repeated immunization leads towards a plateau phase in the number of generated B cells 49 , and it is thought that antigen specific antibodies through cross-linking of BCR and FcγRIIB inhibit B cell responses 15, 16 . This is supported by the fact that mice with genetically deleted Fcreceptors have a very high and largely unregulated immune response after immunization 45, 48 . It appears logical that maternal antibodies regulate B cell responses through the same mechanism. In the case of maternal antibodies, however, these (inhibitory) By ELISPOT, K29 was not able to suppress activation of MV-specific B cells whereas K83 did (* p<0.05; ** p<0.01). F. For a competition ELISPOT, plates were preincubated with increasing amounts of K29 before addition of a constant amount of K83.
Overall, K29 did not influence the inhibitory activity of K83. Subsequently, K71, K83 or L77 antibodies were added to determine whether the respective epitopes recognized by these antibodies were masked by the sera. 
